Y-mAbs
Industry:
Drug development oncology
Website:
Company status:
Public
YmAbs is a clinical stage biotechnology company specialized in developing novel antibody therapeutics to treat cancer. Several ongoing late-stage clinical trials significantly improve survival rates for critical unmet medical needs among cancer patients including pediatric patients.
